Buy Stocks Easy | About Us
April 7, 2020
Buy Stocks Easy | Online Stocks

ACER


Buy Acer Therapeutics Inc. Stock (symbol: ACER) Easy Online

Company Name: Acer Therapeutics Inc.

Symbol: ACER

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2017

ACER Current Share Price

Today's ACER ( Acer Therapeutics Inc. ) opening price: $3.9700

Yesterday's ACER ( Acer Therapeutics Inc. ) closing price: $3.9600

Acer Therapeutics Inc. Stock ( symbol: ACER ) Price Chart since IPO (2017):

12 Months Acer Therapeutics Inc. Stock ( symbol: ACER ) Price Chart

Popular Questions about Acer Therapeutics Inc. Public Stock ( ACER )

A: Acer Therapeutics Inc. stock symbol (also called stock or share ticker) is ACER

A: Acer Therapeutics Inc. IPO (Initial Public Offering) took place on 2017

A: Acer Therapeutics Inc.'s stock (ACER symbol) price at ther IPO (initial Public Offering) was $3.9700

Q: Is ACER stock worth buying at the moment?

A: The ACER stock performance since 2019 are rather disappointing. If you had bought 1 share of Acer Therapeutics Inc. stock (symbol: ACER) at the beginning of 2019, at the opening share price of $24.4900, you would be left with exactly $3.9700 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Acer Therapeutics Inc. Stock Easy Online

Acer Therapeutics Inc. Stock Ticker Price Chart since IPO:





Acer Therapeutics Inc. Stock Price Yesterday



 


Acer Therapeutics Inc. Stock Price – Last Week




 


Acer Therapeutics Inc. Stock Price – Last Month




 


Acer Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1961219/0/en/Acer-Therapeutics-Announces-Full-Enrollment-of-Part-B-in-ACER-001-Pivotal-Bioavailability-and-Bioequivalence-Trial-for-Urea-Cycle-Disorders.html
                            

                                
Acer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders

                                
                                
Part A Successfully Completed and Optimal Formulation of ACER-001 I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936580/0/en/Acer-Therapeutics-Announces-Full-Enrollment-of-Part-A-in-ACER-001-Pivotal-Bioavailability-and-Bioequivalence-Trial-for-Urea-Cycle-Disorders.html
                            

                                
Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders

                                
                                
Results Expected in Q1 2020 with a Planned NDA Submission in Q1 202...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/10/14/strong-q3-pc-sales-boost-the-bullish-argument-for.aspx
                            

                                
Solid PC Sales in Q3 Bolsters Bullish Case for HP, Dell

                                
                                
There are several good reasons that two consecutive quarters of imp...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/27/1907075/0/en/Acer-Therapeutics-to-Present-at-the-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference

                                
                                
NEWTON, Mass., Aug.  27, 2019  (GLOBE NEWSWIRE) -- Acer Therapeutic...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/07/13987454/attention-biotech-investors-mark-your-calendar-for-these-july-pdufa-dates
                            

                                
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

                                
                                
The FDA went overdrive in the month of June, deciding on several re...


                            

                        
                    

                


                            

                    


                        
                            https://investorplace.com/2019/06/acer-therapeutics-news-drops-stock/
                            

                                
Acer Therapeutics News: ACER Stock Plunges on FDA Rejection

                                
                                
Acer Therapeutics news for Tuesday concerning a rejection letter fr...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/06/13977220/acer-therapeutics-shares-plunge-on-fda-complete-response-letter
                            

                                
Acer Therapeutics Shares Plunge On FDA Complete Response Letter

                                
                                
Acer Therapeutics Inc (NASDAQ: ACER) shares were trading down more ...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/acer-therapeutics-receives-crl-from-fda-for-edsivo-stock-halted-for-news-2019-06-25
                            

                                
Acer Therapeutics receives CRL from FDA for Edsivo, stock halted for news

                                
                                
Acer Therapeutics Inc. said Tuesday it received a complete response...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/16/1961219/0/en/Acer-Therapeutics-Announces-Full-Enrollment-of-Part-B-in-ACER-001-Pivotal-Bioavailability-and-Bioequivalence-Trial-for-Urea-Cycle-Disorders.html
                            

                                
Acer Therapeutics Announces Full Enrollment of Part B in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders

                                
                                
Part A Successfully Completed and Optimal Formulation of ACER-001 I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936580/0/en/Acer-Therapeutics-Announces-Full-Enrollment-of-Part-A-in-ACER-001-Pivotal-Bioavailability-and-Bioequivalence-Trial-for-Urea-Cycle-Disorders.html
                            

                                
Acer Therapeutics Announces Full Enrollment of Part A in ACER-001 Pivotal Bioavailability and Bioequivalence Trial for Urea Cycle Disorders

                                
                                
Results Expected in Q1 2020 with a Planned NDA Submission in Q1 202...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/10/14/strong-q3-pc-sales-boost-the-bullish-argument-for.aspx
                            

                                
Solid PC Sales in Q3 Bolsters Bullish Case for HP, Dell

                                
                                
There are several good reasons that two consecutive quarters of imp...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/27/1907075/0/en/Acer-Therapeutics-to-Present-at-the-21st-Annual-H-C-Wainwright-Global-Investment-Conference.html
                            

                                
Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference

                                
                                
NEWTON, Mass., Aug.  27, 2019  (GLOBE NEWSWIRE) -- Acer Therapeutic...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/07/13987454/attention-biotech-investors-mark-your-calendar-for-these-july-pdufa-dates
                            

                                
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates

                                
                                
The FDA went overdrive in the month of June, deciding on several re...


                            

                        
                    

                


                            

                    


                        
                            https://investorplace.com/2019/06/acer-therapeutics-news-drops-stock/
                            

                                
Acer Therapeutics News: ACER Stock Plunges on FDA Rejection

                                
                                
Acer Therapeutics news for Tuesday concerning a rejection letter fr...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/06/13977220/acer-therapeutics-shares-plunge-on-fda-complete-response-letter
                            

                                
Acer Therapeutics Shares Plunge On FDA Complete Response Letter

                                
                                
Acer Therapeutics Inc (NASDAQ: ACER) shares were trading down more ...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/acer-therapeutics-receives-crl-from-fda-for-edsivo-stock-halted-for-news-2019-06-25
                            

                                
Acer Therapeutics receives CRL from FDA for Edsivo, stock halted for news

                                
                                
Acer Therapeutics Inc. said Tuesday it received a complete response...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.